Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 2.19
SIAL's Cash to Debt is ranked higher than
75% of the 1013 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.76 vs. SIAL: 2.19 )
SIAL' s 10-Year Cash to Debt Range
Min: 0.08   Max: 9.98
Current: 2.19

0.08
9.98
Equity to Asset 0.77
SIAL's Equity to Asset is ranked higher than
90% of the 1006 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.52 vs. SIAL: 0.77 )
SIAL' s 10-Year Equity to Asset Range
Min: 0.53   Max: 0.88
Current: 0.77

0.53
0.88
F-Score: 8
Z-Score: 11.60
M-Score: -2.63
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 9/10

vs
industry
vs
history
Operating margin (%) 24.45
SIAL's Operating margin (%) is ranked higher than
98% of the 959 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.85 vs. SIAL: 24.45 )
SIAL' s 10-Year Operating margin (%) Range
Min: 15.5   Max: 25.83
Current: 24.45

15.5
25.83
Net-margin (%) 18.16
SIAL's Net-margin (%) is ranked higher than
97% of the 960 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 3.79 vs. SIAL: 18.16 )
SIAL' s 10-Year Net-margin (%) Range
Min: 10.83   Max: 30.95
Current: 18.16

10.83
30.95
ROE (%) 16.96
SIAL's ROE (%) is ranked higher than
94% of the 954 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 6.91 vs. SIAL: 16.96 )
SIAL' s 10-Year ROE (%) Range
Min: 13.68   Max: 37.26
Current: 16.96

13.68
37.26
ROA (%) 12.90
SIAL's ROA (%) is ranked higher than
97% of the 964 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 3.41 vs. SIAL: 12.90 )
SIAL' s 10-Year ROA (%) Range
Min: 9.05   Max: 23.76
Current: 12.9

9.05
23.76
ROC (Joel Greenblatt) (%) 39.18
SIAL's ROC (Joel Greenblatt) (%) is ranked higher than
96% of the 959 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 11.44 vs. SIAL: 39.18 )
SIAL' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 18.08   Max: 41.11
Current: 39.18

18.08
41.11
Revenue Growth (%) 6.60
SIAL's Revenue Growth (%) is ranked higher than
74% of the 868 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 4.50 vs. SIAL: 6.60 )
SIAL' s 10-Year Revenue Growth (%) Range
Min: 0.4   Max: 16.1
Current: 6.6

0.4
16.1
EBITDA Growth (%) 8.00
SIAL's EBITDA Growth (%) is ranked higher than
79% of the 790 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.40 vs. SIAL: 8.00 )
SIAL' s 10-Year EBITDA Growth (%) Range
Min: 1.9   Max: 18
Current: 8

1.9
18
EPS Growth (%) 9.20
SIAL's EPS Growth (%) is ranked higher than
78% of the 719 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.60 vs. SIAL: 9.20 )
SIAL' s 10-Year EPS Growth (%) Range
Min: 0   Max: 19.7
Current: 9.2

0
19.7
» SIAL's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

SIAL Guru Trades in Q3 2013

Steven Cohen 4,171 sh (New)
Joel Greenblatt 18,393 sh (+126.04%)
Manning & Napier Advisors, Inc 123,090 sh (+66.45%)
Ken Fisher 76,239 sh (+10.69%)
Bill Frels 11,051 sh (+0.92%)
Murray Stahl 276,220 sh (+0.22%)
Yacktman Focused Fund 944,000 sh (unchged)
Yacktman Fund 1,096,000 sh (unchged)
Chuck Royce 18,246 sh (unchged)
John Burbank Sold Out
Ray Dalio Sold Out
Donald Yacktman 2,404,546 sh (-0.66%)
Jeremy Grantham 125,255 sh (-3.54%)
Dodge & Cox 21,000 sh (-4.55%)
Chris Davis 249,264 sh (-9.26%)
Jim Simons 342,432 sh (-11.68%)
First Pacific Advisors 2,900 sh (-25.64%)
» More
Q4 2013

SIAL Guru Trades in Q4 2013

Joel Greenblatt 41,710 sh (+126.77%)
Steven Cohen 6,732 sh (+61.4%)
Bill Frels 11,064 sh (+0.12%)
Yacktman Fund 1,096,000 sh (unchged)
Dodge & Cox 21,000 sh (unchged)
Yacktman Focused Fund 944,000 sh (unchged)
First Pacific Advisors 2,900 sh (unchged)
Donald Yacktman 2,403,515 sh (-0.04%)
Manning & Napier Advisors, Inc 121,060 sh (-1.65%)
Ken Fisher 74,589 sh (-2.16%)
Jeremy Grantham 121,936 sh (-2.65%)
Chris Davis 239,465 sh (-3.93%)
Murray Stahl 246,858 sh (-10.63%)
Chuck Royce 14,000 sh (-23.27%)
Jim Simons 206,600 sh (-39.67%)
» More
Q1 2014

SIAL Guru Trades in Q1 2014

Jeremy Grantham 236,278 sh (+93.77%)
Steven Cohen 12,253 sh (+82.01%)
Jim Simons 313,300 sh (+51.65%)
Chris Davis 241,179 sh (+0.72%)
Yacktman Focused Fund 944,000 sh (unchged)
Yacktman Fund 1,096,000 sh (unchged)
Bill Frels 11,064 sh (unchged)
Chuck Royce Sold Out
Donald Yacktman 2,397,543 sh (-0.25%)
Ken Fisher 73,189 sh (-1.88%)
Dodge & Cox 20,500 sh (-2.38%)
First Pacific Advisors 2,700 sh (-6.9%)
Joel Greenblatt 38,703 sh (-7.21%)
Murray Stahl 218,865 sh (-11.34%)
Manning & Napier Advisors, Inc 105,840 sh (-12.57%)
» More
Q2 2014

SIAL Guru Trades in Q2 2014

Manning & Napier Advisors, Inc 106,110 sh (+0.26%)
Yacktman Focused Fund 944,000 sh (unchged)
Yacktman Fund 1,096,000 sh (unchged)
Ken Fisher 72,039 sh (-1.57%)
» More
» Details

Insider Trades

Latest Guru Trades with SIAL

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2013-12-31 Add 126.77%0.05%$82.91 - $94.19 $ 103.4319%41710
John Burbank 2013-09-30 Sold Out 0.05%$80.9 - $88 $ 103.4323%0
Joel Greenblatt 2013-09-30 Add 126.04%0.03%$80.9 - $88 $ 103.4323%18393
Ray Dalio 2013-09-30 Sold Out $80.9 - $88 $ 103.4323%0
Yacktman Focused Fund 2013-06-30 Add 94.88%0.46%$74.1 - $85.14 $ 103.4329%944000
Yacktman Fund 2013-06-30 Add 94.29%0.46%$74.1 - $85.14 $ 103.4329%1096000
Donald Yacktman 2013-06-30 Add 94.43%0.45%$74.1 - $85.14 $ 103.4329%2420445
Vanguard Health Care Fund 2013-06-30 Sold Out 0.15%$74.1 - $85.14 $ 103.4329%0
John Burbank 2013-06-30 New Buy0.05%$74.1 - $85.14 $ 103.4329%20000
Joel Greenblatt 2013-06-30 New Buy0.03%$74.1 - $85.14 $ 103.4329%8137
Ray Dalio 2013-06-30 New Buy$74.1 - $85.14 $ 103.4329%3227
Vanguard Health Care Fund 2013-03-31 Reduce -85.11%0.54%$73.58 - $78.95 $ 103.4334%488400
Yacktman Fund 2013-03-31 New Buy0.52%$73.58 - $78.95 $ 103.4334%564100
Yacktman Focused Fund 2013-03-31 New Buy0.51%$73.58 - $78.95 $ 103.4334%484400
Donald Yacktman 2013-03-31 New Buy0.5%$73.58 - $78.95 $ 103.4334%1244900
John Burbank 2012-12-31 Sold Out 0.38%$68.79 - $74.36 $ 103.4344%0
John Burbank 2012-09-30 Add 305.98%0.29%$67.13 - $74.34 $ 103.4344%116200
John Burbank 2012-06-30 New Buy0.07%$67.57 - $73.84 $ 103.4346%28622
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about Sigma-Aldrich Corp

Weekly 52-Week Highs Highlight: MGM, SIAL, ADBE, LVS
According to GuruFocus list of 52-week highs; MGM Resorts International, Sigma-Aldrich Corp., Adobe Systems Inc. and Las Vegas Sands Corp. have all reached their 52-week highs. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 25.20
SIAL's P/E(ttm) is ranked higher than
66% of the 1046 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 23.70 vs. SIAL: 25.20 )
SIAL' s 10-Year P/E(ttm) Range
Min: 12.12   Max: 25.63
Current: 25.2

12.12
25.63
P/B 4.20
SIAL's P/B is ranked lower than
57% of the 1046 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.78 vs. SIAL: 4.20 )
SIAL' s 10-Year P/B Range
Min: 2.87   Max: 4.88
Current: 4.2

2.87
4.88
P/S 4.60
SIAL's P/S is ranked lower than
61% of the 1046 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.06 vs. SIAL: 4.60 )
SIAL' s 10-Year P/S Range
Min: 1.92   Max: 4.6
Current: 4.6

1.92
4.6
PFCF 22.50
SIAL's PFCF is ranked higher than
79% of the 1046 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 58.49 vs. SIAL: 22.50 )
SIAL' s 10-Year PFCF Range
Min: 12.57   Max: 25.94
Current: 22.5

12.57
25.94
EV-to-EBIT 17.70
SIAL's EV-to-EBIT is ranked higher than
72% of the 1046 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 18.45 vs. SIAL: 17.70 )
SIAL' s 10-Year EV-to-EBIT Range
Min: 8.8   Max: 20.2
Current: 17.7

8.8
20.2
PEG 2.80
SIAL's PEG is ranked higher than
80% of the 1046 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 14.18 vs. SIAL: 2.80 )
SIAL' s 10-Year PEG Range
Min: 0.89   Max: 2.91
Current: 2.8

0.89
2.91
Shiller P/E 28.70
SIAL's Shiller P/E is ranked higher than
83% of the 1046 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 9999.00 vs. SIAL: 28.70 )
SIAL' s 10-Year Shiller P/E Range
Min: 15.13   Max: 32.49
Current: 28.7

15.13
32.49
Current Ratio 4.99
SIAL's Current Ratio is ranked higher than
95% of the 1010 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.78 vs. SIAL: 4.99 )
SIAL' s 10-Year Current Ratio Range
Min: 1.54   Max: 7.34
Current: 4.99

1.54
7.34
Quick Ratio 3.20
SIAL's Quick Ratio is ranked higher than
92% of the 1010 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.21 vs. SIAL: 3.20 )
SIAL' s 10-Year Quick Ratio Range
Min: 0.58   Max: 3.47
Current: 3.2

0.58
3.47

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.90
SIAL's Dividend Yield is ranked lower than
75% of the 810 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.54 vs. SIAL: 0.90 )
SIAL' s 10-Year Dividend Yield Range
Min: 0.77   Max: 1.64
Current: 0.9

0.77
1.64
Dividend Payout 0.24
SIAL's Dividend Payout is ranked higher than
89% of the 1046 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 4.37 vs. SIAL: 0.24 )
SIAL' s 10-Year Dividend Payout Range
Min: 0.03   Max: 0.24
Current: 0.24

0.03
0.24
Dividend growth (3y) 10.40
SIAL's Dividend growth (3y) is ranked higher than
83% of the 524 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 4.20 vs. SIAL: 10.40 )
SIAL' s 10-Year Dividend growth (3y) Range
Min: 5.3   Max: 30
Current: 10.4

5.3
30
Yield on cost (5-Year) 1.49
SIAL's Yield on cost (5-Year) is ranked lower than
59% of the 816 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.89 vs. SIAL: 1.49 )
SIAL' s 10-Year Yield on cost (5-Year) Range
Min: 1.27   Max: 2.71
Current: 1.49

1.27
2.71
Share Buyback Rate 0.50
SIAL's Share Buyback Rate is ranked higher than
84% of the 604 Companies
in the Global Specialty Chemicals industry.

( Industry Median: -0.80 vs. SIAL: 0.50 )
SIAL' s 10-Year Share Buyback Rate Range
Min: 10.1   Max: -0.5
Current: 0.5

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 24.00
SIAL's Price/Net Current Asset Value is ranked higher than
86% of the 1046 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 9999.00 vs. SIAL: 24.00 )
SIAL' s 10-Year Price/Net Current Asset Value Range
Min: 10.24   Max: 3598.6
Current: 24

10.24
3598.6
Price/Tangible Book 6.10
SIAL's Price/Tangible Book is ranked lower than
57% of the 1046 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 2.14 vs. SIAL: 6.10 )
SIAL' s 10-Year Price/Tangible Book Range
Min: 2.35   Max: 6.68
Current: 6.1

2.35
6.68
Price/DCF (Projected) 1.70
SIAL's Price/DCF (Projected) is ranked higher than
85% of the 1046 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 9999.00 vs. SIAL: 1.70 )
SIAL' s 10-Year Price/DCF (Projected) Range
Min: 0.9   Max: 2.94
Current: 1.7

0.9
2.94
Price/Median PS Value 1.50
SIAL's Price/Median PS Value is ranked lower than
52% of the 1046 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.11 vs. SIAL: 1.50 )
SIAL' s 10-Year Price/Median PS Value Range
Min: 0.62   Max: 1.45
Current: 1.5

0.62
1.45
Price/Peter Lynch Fair Value 2.90
SIAL's Price/Peter Lynch Fair Value is ranked higher than
85% of the 1046 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 9999.00 vs. SIAL: 2.90 )
SIAL' s 10-Year Price/Peter Lynch Fair Value Range
Min: 1.03   Max: 5
Current: 2.9

1.03
5
Price/Graham Number 2.60
SIAL's Price/Graham Number is ranked higher than
59% of the 1046 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.80 vs. SIAL: 2.60 )
SIAL' s 10-Year Price/Graham Number Range
Min: 1.38   Max: 2.66
Current: 2.6

1.38
2.66
Earnings Yield (Greenblatt) 5.60
SIAL's Earnings Yield (Greenblatt) is ranked higher than
65% of the 911 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 6.40 vs. SIAL: 5.60 )
SIAL' s 10-Year Earnings Yield (Greenblatt) Range
Min: 5   Max: 11.3
Current: 5.6

5
11.3
Forward Rate of Return (Yacktman) 11.30
SIAL's Forward Rate of Return (Yacktman) is ranked higher than
80% of the 746 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 7.09 vs. SIAL: 11.30 )
SIAL' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 11.8   Max: 19.7
Current: 11.3

11.8
19.7

Business Description

Industry: Chemicals » Specialty Chemicals
Compare:NEU, SCL, VAL, POL, CYT » details
Traded in other countries:SIQ.Germany
Sigma-Aldrich Corporation was incorporated under the laws of the State of Delaware in May 1975. The Company is a Life Science and High Technology company. It develops, manufactures, purchases and distributes the range of high quality chemicals, biochemicals and equipment available throughout the world. These chemical products and kits are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development and as key components in pharmaceutical, diagnostic and other high technology manufacturing. On January 31, 2012, the Company acquired BioReliance Holdings, Inc. (BioReliance), a provider of global biopharmaceutical testing services. BioReliance had $126 million of sales in 2011. The Company operates in 37 countries, manufacturing approximately 50,000 of the 170,000 chemical and biochemical products it offers. The Company also offers approximately 45,000 equipment products. The Company sells into 160 countries, servicing over 97,000 accounts representing over 1.4 million individual customers. The Company provides products that focus on: research customers that use smaller quantities of its products in basic life science and high-technology research and development, and manufacturing customers that use its products in larger quantities in lab-stage development and manufacturing. It is organized into a customer-centric structure featuring the Research units of Essentials, Specialties and Biotech and a Fine Chemicals unit, SAFC. The Research Essentials unit sells biological buffers, cell culture reagents, biochemicals, chemicals, solvents, and other reagents and kits. The Research Specialties unit sells organic chemicals, biochemicals, analytical reagents, chromatography and other laboratory consumables, reference materials and high-purity products which are generally sold in smaller volumes to the lab scientist customer. The Research Biotech unit supplies immunochemical, molecular biology, cell biology, proteomic, genomic, transgenic and other life science products to academic, government, industrial, biotechnology and pharmaceutical research customers. The SAFC (Fine Chemicals) unit is a top 10 supplier of large-scale organic chemicals and biochemicals used in development and production by pharmaceutical, biotechnology, industrial, diagnostic and electronics companies. The Company's trademarks are the brand names: Sigma-Aldrich, Sigma, Aldrich, Fluka, Riedel-de Haen, Supelco, SAFC, SAFC Biosciences, SAFC Supply Solutions, SAFC Pharma, SAFC Hitech, Genosys, Proligo and Pharmorphix. In all product areas, the Company competes mainly on the basis of customer service, product availability, quality and price.
» More Articles for SIAL

Headlines

Articles On GuruFocus.com
Top Three Holdings with Promising Outlook Jul 15 2014 
High Trade Volume, and Gurus’ 2013 Preferred Stock Apr 21 2014 
Weekly 52-Week Highs Highlight: MGM, SIAL, ADBE, LVS Dec 16 2013 
Weekly Top Insider Buys: Apache Corporation, Sigma-Aldrich Corporation, Huntington Bancshares, Ameri Sep 09 2013 
Donald Yacktman's Top Second Quarter Increases Jul 30 2013 
Yacktman Fund Buys Oracle, Exxon Mobil, C.R. Bard, Sells Pfizer, Viacom, Microsoft Jul 17 2013 
Donald Yacktman Buys Wells Fargo, Oracle Jul 16 2013 
The Yacktman Fund's Top 5 Second Quarter Increases Jul 16 2013 
Are Donald Yacktman's New Buys Undervalued? Jun 12 2013 
potential buy in fut May 14 2013 


More From Other Websites
Sigma-Aldrich (SIAL) Beats on Earnings, Misses on Revenues Jul 24 2014
Sigma-Aldrich (NASDAQ - SIAL) Reports Record Q2 2014 Results With Sales Of $701 Million And Diluted... Jul 24 2014
SIGMA ALDRICH CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 24 2014
Q2 2014 Sigma-Aldrich Corporation Earnings Release - Before Market Open Jul 24 2014
Sigma-Aldrich (NASDAQ - SIAL) Reports Record Q2 2014 Results With Sales Of $701 Million And Diluted... Jul 24 2014
Will Sigma-Aldrich (SIAL) Keep the Earnings Streak Alive? Jul 23 2014
James J. Owens, the President and CEO of H.B. Fuller Company (FUL), Interviews with The Wall Street... Jul 21 2014
Sigma-Aldrich Announces Q2 2014 Earnings Conference Call and Cash Dividend Jul 09 2014
Sigma-Aldrich Announces Q2 2014 Earnings Conference Call and Cash Dividend Jul 09 2014
Sigma-Aldrich Touches New 52-Week High Jul 09 2014
Sigma-Aldrich, One of ‘Greenest’ Firms, Sued Over Excessive Pay Jul 02 2014
Director/PDMR Shareholding Jul 01 2014
Director/PDMR Shareholding Jul 01 2014
Total Voting Rights Jul 01 2014
Sigma-Aldrich, Applied Genetic in Gene Therapy Alliance Jun 25 2014
Applied Genetic, SAFC Commercial announce partnership Jun 24 2014
AGTC and SAFC Create Strategic Partnership to Provide Gene Therapy Manufacturing Services Jun 24 2014
Today Sigma-Aldrich (SIAL) Hits New Lifetime High Jun 20 2014
Today Sigma-Aldrich (SIAL) Hits New Lifetime High Jun 09 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide